StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences net income

Net income is the profit left for shareholders after every expense, interest and tax.

Panacea Life Sciences's net income for the twelve months ending Mar 31, 2024 was -$7.67M. For fiscal 2023 it was -$8.02M. The highest annual figure on record is -$296.57K in fiscal 2014.

Annual net income

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$8.02M–
FY2022Dec 31, 2022-$9.14M–
FY2021Dec 31, 2021-$4.78M–
FY2020Dec 31, 2020-$5.23M–
FY2019Dec 31, 2019-$10.02M–
FY2018Dec 31, 2018-$4.34M–
FY2017Dec 31, 2017-$3.86M–
FY2016Dec 31, 2016-$1.60M–
FY2015Dec 31, 2015-$357.98K–
FY2014Dec 31, 2014-$296.57K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024-$1.45M–
Q4 FY2023Dec 31, 2023-$2.21M–
Q3 FY2023Sep 30, 2023-$2.15M–
Q2 FY2023Jun 30, 2023-$1.86M–
Q1 FY2023Mar 31, 2023-$1.79M–
Q4 FY2022Dec 31, 2022-$1.70M–
Q3 FY2022Sep 30, 2022-$2.69M–
Q2 FY2022Jun 30, 2022-$1.96M-7308.8%
Q1 FY2022Mar 31, 2022-$2.78M-850.6%
Q4 FY2021Dec 31, 2021-$2.09M–
Q3 FY2021Sep 30, 2021-$3.09M–
Q2 FY2021Jun 30, 2021$27.21K-95.8%
Q1 FY2021Mar 31, 2021$370.65K–
Q4 FY2020Dec 31, 2020-$87.50K–
Q3 FY2020Sep 30, 2020-$3.78M–
Q2 FY2020Jun 30, 2020$655.22K–
Q1 FY2020Mar 31, 2020-$2.82M–
Q4 FY2019Dec 31, 2019-$5.48M–
Q3 FY2019Sep 30, 2019-$2.03M–
Q2 FY2019Jun 30, 2019-$2.03M–
Q1 FY2019Mar 31, 2019-$1.41M–
Q4 FY2018Dec 31, 2018-$1.11M–
Q3 FY2018Sep 30, 2018-$1.60M–
Q2 FY2018Jun 30, 2018-$559.71K–
Q1 FY2018Mar 31, 2018-$1.07M–
Q4 FY2017Dec 31, 2017-$2.04M–
Q3 FY2017Sep 30, 2017-$717.82K–
Q2 FY2017Jun 30, 2017-$506.30K–
Q1 FY2017Mar 31, 2017-$601.01K–
Q4 FY2016Dec 31, 2016-$747.43K–
Q3 FY2016Sep 30, 2016-$359.81K–
Q2 FY2016Jun 30, 2016-$260.87K–
Q1 FY2016Mar 31, 2016-$234.82K–
Q4 FY2015Dec 31, 2015-$28.36K–
Q1 FY2015Mar 31, 2015-$63.81K–
Q4 FY2014Dec 31, 2014-$240.45K–
Q3 FY2014Sep 30, 2014-$74.89K–
Q2 FY2014Jun 30, 2014-$7.67K–

More Panacea Life Sciences figures

See a number that looks wrong?